shahina daar
shahina daar
Professor, Dept of Hematology, College of Medicine, Sultan Qaboos University
No verified email
Cited by
Cited by
Overview on practices in thalassemia intermedia management aiming for lowering complication rates across a region of endemicity: the OPTIMAL CARE study
AT Taher, KM Musallam, M Karimi, A El-Beshlawy, K Belhoul, S Daar, ...
Blood, The Journal of the American Society of Hematology 115 (10), 1886-1892, 2010
Efficacy and safety of deferasirox, an oral iron chelator, in heavily iron‐overloaded patients with β‐thalassaemia: the ESCALATOR study
A Taher, A El‐Beshlawy, MS Elalfy, K Al Zir, S Daar, D Habr, ...
European journal of haematology 82 (6), 458-465, 2009
β-thalassemia distribution in the old world: an ancient disease seen from a historical standpoint
V De Sanctis, C Kattamis, D Canatan, AT Soliman, H Elsedfy, M Karimi, ...
Mediterranean journal of hematology and infectious diseases 9 (1), 2017
Cytokine profile of sickle cell disease in Oman
A Pathare, S Al Kindi, AA Alnaqdy, S Daar, H Knox‐Macaulay, ...
American journal of hematology 77 (4), 323-328, 2004
Splenectomy and thrombosis: the case of thalassemia intermedia
AT Taher, KM Musallam, M Karimi, A El‐Beshlawy, K Belhoul, S Daar, ...
Journal of Thrombosis and Haemostasis 8 (10), 2152-2158, 2010
Chronic myeloid leukemia patients with the e13a2 BCR-ABL fusion transcript have inferior responses to imatinib compared to patients with the e14a2 transcript
CM Lucas, RJ Harris, A Giannoudis, A Davies, K Knight, SJ Watmough, ...
haematologica 94 (10), 1362, 2009
Age‐related complications in treatment‐naive patients with thalassaemia intermedia
AT Taher, KM Musallam, A El‐Beshlawy, M Karimi, S Daar, K Belhoul, ...
British journal of haematology 150 (4), 486-489, 2010
Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload
S Daar, AV Pathare
Annals of hematology 85 (5), 315-319, 2006
Multicenter validation of spin‐density projection‐assisted R2‐MRI for the noninvasive measurement of liver iron concentration
TG St Pierre, A El‐Beshlawy, M Elalfy, A Al Jefri, K Al Zir, S Daar, D Habr, ...
Magnetic resonance in medicine 71 (6), 2215-2223, 2014
Cytokines in sickle cell disease
A Pathare, SA Kindi, S Daar, D Dennison
Hematology 8 (5), 329-337, 2003
Reduction in labile plasma iron during treatment with deferasirox, a once‐daily oral iron chelator, in heavily iron‐overloaded patients with β‐thalassaemia
S Daar, A Pathare, H Nick, U Kriemler‐Krahn, A Hmissi, D Habr, A Taher
European journal of haematology 82 (6), 454-457, 2009
Forecasting hemoglobinopathy burden through neonatal screening in Omani neonates
S Alkindi, S Al Zadjali, A Al Madhani, S Daar, H Al Haddabi, Q Al Abri, ...
Hemoglobin 34 (2), 135-144, 2010
Frequency and clinical significance of erythrocyte genetic abnormalities in Omanis.
JM White, BS Christie, D Nam, S Daar, DR Higgs
Journal of medical genetics 30 (5), 396-400, 1993
Deferasirox (Exjade®) significantly improves cardiac T2* in heavily iron-overloaded patients with β-thalassemia major
A Pathare, A Taher, S Daar
Annals of hematology 89 (4), 405-409, 2010
JAK2 p. V617F allele burden in myeloproliferative neoplasms one month after allogeneic stem cell transplantation significantly predicts outcome and risk of relapse
T Lange, A Edelmann, U Siebolts, R Krahl, C Nehring, N Jäkel, M Cross, ...
haematologica 98 (5), 722, 2013
Risk factors for pulmonary hypertension in patients with β thalassemia intermedia
M Karimi, KM Musallam, MD Cappellini, S Daar, A El-Beshlawy, K Belhoul, ...
European Journal of Internal Medicine 22 (6), 607-610, 2011
Molecular characterization of G6PD deficiency in Oman
S Daar, TJ Vulliamy, J Kaeda, PJ Mason, L Luzzatto
Human heredity 46 (3), 172-176, 1996
A community-based study of common hereditary blood disorders in Oman
AA Al Riyami, AJ Suleiman, M Afifi, ZM Al Lamki, S Daar
EMHJ-Eastern Mediterranean Health Journal, 7 (6), 1004-1011, 2001, 2001
Serum ferritin level and morbidity risk in transfusion-independent patients with β-thalassemia intermedia: the ORIENT study
KM Musallam, MD Cappellini, S Daar, M Karimi, A El-Beshlawy, ...
Haematologica 99 (11), e218, 2014
Improved treatment satisfaction and convenience with deferasirox in iron-overloaded patients with β-thalassemia: results from the ESCALATOR trial
A Taher, A Al Jefri, MS Elalfy, K Al Zir, S Daar, D Rofail, JF Baladi, D Habr, ...
Acta Haematologica 123 (4), 220-225, 2010
The system can't perform the operation now. Try again later.
Articles 1–20